Department of Neuropsychiatry, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
Department of Neuropsychiatry, Okayama University Hospital, Okayama, Japan.
BMJ Open. 2022 Jun 14;12(6):e060621. doi: 10.1136/bmjopen-2021-060621.
We examined the efficacy of case management (CM) interventions to encourage participation in colorectal cancer screening for patients with schizophrenia. This study aimed to clarify patients' acceptability of the intervention and the helpful components of the intervention. Simultaneously, the study aimed to determine the acceptability, appropriateness and feasibility of the intervention from the perspective of psychiatric care providers.
This study was a secondary qualitative analysis of a mixed-method randomised controlled trial that evaluated the efficacy of the CM approach to encourage participation in cancer screening for people with schizophrenia. The intervention comprised education and patient navigation for colorectal cancer screening. Interviews were conducted with patients who received the intervention and staff from two psychiatric hospitals in Japan who delivered the intervention.
Of the 172 patients with schizophrenia who participated in the trial, 153 were included. In addition, three out of six providers were included.
Using a structured interview, the case manager asked participants about patient acceptability and the helpful components of the intervention. Content analysis was conducted for the responses obtained, and the number of responses was tabulated by two researchers. For the interviews with the providers, opinions obtained from verbatim transcripts were extracted and summarised.
Forty-three of the 56 patients perceived that the intervention was acceptable. For the intervention component, inperson counselling with an explanation of the screening process by psychiatric care providers was most frequently reported by the patients as helpful (48 of the 68 respondents). Psychiatric care providers evaluated the intervention as acceptable, appropriate and easy to understand and administer. However, providing the intervention to all patients simultaneously was considered difficult with the current human resources.
This study showed that the CM intervention was perceived as acceptable by patients and acceptable and appropriate by psychiatric care providers.
UMIN000036017.
本研究旨在探讨病例管理（CM）干预措施在鼓励精神分裂症患者参与结直肠癌筛查方面的效果。本研究旨在明确患者对干预措施的接受程度和干预措施的有益组成部分。同时，本研究旨在从精神科护理提供者的角度确定干预措施的可接受性、适宜性和可行性。
这是一项混合方法随机对照试验的二次定性分析，评估了 CM 方法对鼓励精神分裂症患者参与癌症筛查的效果。干预措施包括结直肠癌筛查的教育和患者导航。对接受干预的患者和在日本两家精神病院提供干预的工作人员进行了访谈。
在参与试验的 172 名精神分裂症患者中，有 153 名患者被纳入。此外，还纳入了 6 名提供者中的 3 名。
使用结构化访谈，病例管理员询问患者对干预措施的接受程度和有用组成部分的看法。对获得的回复进行内容分析，并由两名研究人员对回复数量进行制表。对于与提供者的访谈，从逐字记录中提取并总结了意见。
56 名患者中有 43 名认为干预措施是可以接受的。在干预措施组成部分中，精神科护理提供者亲自进行咨询并解释筛查过程，这是患者最常报告的有用部分（68 名受访者中有 48 名）。精神科护理提供者认为该干预措施是可接受的、适宜的，易于理解和实施。然而，考虑到目前的人力资源，同时向所有患者提供该干预措施被认为是困难的。
本研究表明，CM 干预措施被患者认为是可以接受的，被精神科护理提供者认为是可以接受和适宜的。
UMIN000036017。
